MyoKardia

Estuary Biotherapeutics launches to treat kidney disease with gene therapies

Estuary Biotherapeutics launched to develop gene therapies for kidney disease, founded by ex-MyoKardia CEO Wayne Sackett. The company plans to translate research showing reactivating Pkd genes can rev